Transcatheter closure of intracardiac defects in adults

Journal of Interventional Cardiology

Volumn 20, Issue 6, 2007, Pages 524-545

  Kim, Michael S ^a   Klein, Andrew J ^a   Carroll, John D ^a  

^a UNIVERSITY OF COLORADO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CONGENITAL HEART DISEASE; ECHOCARDIOGRAPHY; FLUOROSCOPY; HEART ATRIUM SEPTUM DEFECT; HEART SEPTUM DEFECT; HEART VENTRICLE SEPTUM DEFECT; HUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; REVIEW; SURGICAL TECHNIQUE; TREATMENT INDICATION;

ADULT; CLINICAL COMPETENCE; CORONARY CIRCULATION; EMBOLISM, PARADOXICAL; HEART ATRIA; HEART CATHETERIZATION; HEART SEPTAL DEFECTS; HEART SEPTAL DEFECTS, ATRIAL; HEART SEPTAL DEFECTS, VENTRICULAR; HUMANS; MIGRAINE DISORDERS; PATIENT SELECTION; PROSTHESES AND IMPLANTS; PROSTHESIS DESIGN; PROSTHESIS IMPLANTATION; RANDOMIZED CONTROLLED TRIALS AS TOPIC; TOMOGRAPHY, X-RAY COMPUTED;

EID: 36549060489     PISSN: 08964327     EISSN: 15408183     Source Type: Journal    
DOI: 10.1111/j.1540-8183.2007.00304.x     Document Type: Review

References (135)

1. Lamy C, Giannesini C, Zuber M, et al. Clinical and imaging findings in cryptogenic stroke patients with and without patent foramen ovale: The PFO-ASA Study. Atrial Septal Aneurysm. Stroke 2002 33 : 706 711.
2. Wu LA, Malouf JF, Dearani JA, et al. Patent foramen ovale in cryptogenic stroke: Current understanding and management options. Arch Intern Med 2004 164 : 950 956.
3. Chen GP, Goldberg SL, Gill EA, Jr. Patent foramen ovale and the platypnea-orthodeoxia syndrome. Cardiol Clin 2005 23 : 85 89.
4. Cheng TO. Platypnea-orthodeoxia syndrome: Etiology, differential diagnosis, and management. Catheter Cardiovasc Interv 1999 47 : 64 66.
5. Cartoni D, De Castro S, Valente G, et al. Identification of professional scuba divers with patent foramen ovale at risk for decompression illness. Am J Cardiol 2004 94 : 270 273.
6. Germonpre P. Patent foramen ovale and diving. Cardiol Clin 2005 23 : 97 104.
7. Moon RE, Camporesi EM, Kisslo JA. Patent foramen ovale and decompression sickness in divers. Lancet 1989 1 : 513 514.
8. Allemann Y, Hutter D, Lipp E, et al. Patent foramen ovale and high-altitude pulmonary edema. JAMA 2006 296 : 2954 2958.
9. Cheng TO. Patent foramen ovale in high-altitude pulmonary edema: A vicious cycle. Int J Cardiol 2007.
10. Johansson MC, Eriksson P, Peker Y, et al. The influence of patent foramen ovale on oxygen desaturation in obstructive sleep apnoea. Eur Respir J 2007 29 : 149 155.
11. Post MC, Luermans JG, Plokker HW, et al. Patent foramen ovale and migraine. Catheter Cardiovasc Interv 2007 69 : 9 14.
12. Bridges ND, Hellenbrand W, Latson L, et al. Transcatheter closure of patent foramen ovale after presumed paradoxical embolism. Circulation 1992 86 : 1902 1908.
13. Meier B, Lock JE. Contemporary management of patent foramen ovale. Circulation 2003 107 : 5 9.
14. Wahl A, Meier B, Haxel B, et al. Prognosis after percutaneous closure of patent foramen ovale for paradoxical embolism. Neurology 2001 57 : 1330 1332.
15. Gill EA, Jr. Definitions and pathophysiology of the patent foramen ovale: Broad overview. Cardiol Clin 2005 23 : 1 6.
16. Mugge A, Daniel WG, Angermann C, et al. Atrial septal aneurysm in adult patients. A multicenter study using transthoracic and transesophageal echocardiography. Circulation 1995 91 : 2785 2792.
17. Hausmann D, Mugge A, Daniel WG. Identification of patent foramen ovale permitting paradoxic embolism. J Am Coll Cardiol 1995 26 : 1030 1038.
18. Overell JR, Bone I, Lees KR. Interatrial septal abnormalities and stroke: A meta-analysis of case-control studies. Neurology 2000 55 : 1172 1179.
19. Ho SY, McCarthy KP, Rigby ML. Morphological features pertinent to interventional closure of patent oval foramen. J Interv Cardiol 2003 16 : 33 38.
20. Windecker S, Wahl A, Chatterjee T, et al. Percutaneous closure of patent foramen ovale in patients with paradoxical embolism: Long-term risk of recurrent thromboembolic events. Circulation 2000 101 : 893 898.
21. Mohr JP, Thompson JL, Lazar RM, et al. A comparison of warfarin and aspirin for the prevention of recurrent ischemic stroke. N Engl J Med 2001 345 : 1444 1451.
22. Mas JL, Arquizan C, Lamy C, et al. Recurrent cerebrovascular events associated with patent foramen ovale, atrial septal aneurysm, or both. N Engl J Med 2001 345 : 1740 1746.
23. Bogousslavsky J, Garazi S, Jeanrenaud X, et al. Stroke recurrence in patients with patent foramen ovale: The Lausanne Study. Lausanne Stroke with Paradoxal Embolism Study Group. Neurology 1996 46 : 1301 1305.
24. Cheng TO. Transcatheter closure of patent foramen ovale: A definitive treatment for platypnea-orthodeoxia. Catheter Cardiovasc Interv 2000 51 : 120.
25. Guerin P, Lambert V, Godart F, et al. Transcatheter closure of patent foramen ovale in patients with platypnea-orthodeoxia: Results of a multicentric French registry. Cardiovasc Intervent Radiol 2005 28 : 164 168.
26. Waight DJ, Cao QL, Hijazi ZM. Closure of patent foramen ovale in patients with orthodeoxia-platypnea using the amplatzer devices. Catheter Cardiovasc Interv 2000 50 : 195 198.
27. Godart F, Rey C, Prat A, et al. Atrial right-to-left shunting causing severe hypoxaemia despite normal right-sided pressures. Report of 11 consecutive cases corrected by percutaneous closure. Eur Heart J 2000 21 : 483 489.
28. Marenco J, Naimi S, Hijazi Z, et al. Nonsurgical closure of a patent foramen ovale in a patient with carcinoid heart disease and severe hypoxia from interatrial shunting. Catheter Cardiovasc Interv 2000 51 : 210 213.
29. Schwerzmann M, Nedeltchev K, Lagger F, et al. Prevalence and size of directly detected patent foramen ovale in migraine with aura. Neurology 2005 65 : 1415 1418.
30. Schwerzmann M, Nedeltchev K, Meier B. Patent foramen ovale closure: A new therapy for migraine. Catheter Cardiovasc Interv 2007 69 : 277 284.
31. Gupta A, Kapoor G, Dalvi B. Transcatheter closure of atrial septal defects. Expert Rev Cardiovasc Ther 2004 2 : 713 719.
32. Anzai H, Child J, Natterson B, et al. Incidence of thrombus formation on the CardioSEAL and the Amplatzer interatrial closure devices. Am J Cardiol 2004 93 : 426 431.
33. Mullen MJ, Hildick-Smith D, De Giovanni JV, et al. BioSTAR Evaluation STudy (BEST): A prospective, multicenter, phase I clinical trial to evaluate the feasibility, efficacy, and safety of the BioSTAR bioabsorbable septal repair implant for the closure of atrial-level shunts. Circulation 2006 114 : 1962 1967.
34. Meier B. Closure of patent foramen ovale: Technique, pitfalls, complications, and follow up. Heart 2005 91 : 444 448.
35. Trepels T, Zeplin H, Sievert H, et al. Cardiac perforation following transcatheter PFO closure. Catheter Cardiovasc Interv 2003 58 : 111 113.
36. Dearani JA, Ugurlu BS, Danielson GK, et al. Surgical patent foramen ovale closure for prevention of paradoxical embolism-related cerebrovascular ischemic events. Circulation 1999 100 : II171 II175.
37. Bartel T, Konorza T, Neudorf U, et al. Intracardiac echocardiography: An ideal guiding tool for device closure of interatrial communications. Eur J Echocardiogr 2005 6 : 92 96.
38. Earing MG, Cabalka AK, Seward JB, et al. Intracardiac echocardiographic guidance during transcatheter device closure of atrial septal defect and patent foramen ovale. Mayo Clin Proc 2004 79 : 24 34.
39. Carroll JD, Dodge S, Groves BM. Percutaneous patent foramen ovale closure. Cardiol Clin 2005 23 : 13 33.
40. Krumsdorf U, Ostermayer S, Billinger K, et al. Incidence and clinical course of thrombus formation on atrial septal defect and patient foramen ovale closure devices in 1,000 consecutive patients. J Am Coll Cardiol 2004 43 : 302 309.
41. Braun M, Gliech V, Boscheri A, et al. Transcatheter closure of patent foramen ovale (PFO) in patients with paradoxical embolism. Periprocedural safety and mid-term follow-up results of three different device occluder systems. Eur Heart J 2004 25 : 424 430.
42. Post MC, Van Deyk K, Budts W. Percutaneous closure of a patent foramen ovale: Single-centre experience using different types of devices and mid-term outcome. Acta Cardiol 2005 60 : 515 519.
43. Slavin L, Tobis JM, Rangarajan K, et al. Five-year experience with percutaneous closure of patent foramen ovale. Am J Cardiol 2007 99 : 1316 1320.
44. Lai DW, Saver JL, Araujo JA, et al. Pericarditis associated with nickel hypersensitivity to the Amplatzer occluder device: A case report. Catheter Cardiovasc Interv 2005 66 : 424 426.
45. Singh HR, Turner DR, Forbes TJ. Nickel allergy and the amplatzer septal occluder. J Invasive Cardiol 2004 16 : 681 682.
46. McMahon CJ, Feltes TF, Fraley JK, et al. Natural history of growth of secundum atrial septal defects and implications for transcatheter closure. Heart 2002 87 : 256 259.
47. Basson CT, Huang T, Lin RC, et al. Different TBX5 interactions in heart and limb defined by Holt-Oram syndrome mutations. Proc Natl Acad Sci U S A 1999 96 : 2919 2924.
48. Burn J, Brennan P, Little J, et al. Recurrence risks in offspring of adults with major heart defects: Results from first cohort of British collaborative study. Lancet 1998 351 : 311 316.
49. Uebing A, Steer PJ, Yentis SM, et al. Pregnancy and congenital heart disease. BMJ 2006 332 : 401 406.
50. King TD, Thompson SL, Steiner C, et al. Secundum atrial septal defect. Nonoperative closure during cardiac catheterization. JAMA 1976 235 : 2506 2509.
51. Prieto LR, Foreman CK, Cheatham JP, et al. Intermediate-term outcome of transcatheter secundum atrial septal defect closure using the Bard Clamshell Septal Umbrella. Am J Cardiol 1996 78 : 1310 1312.
52. Rao PS, Berger F, Rey C, et al. Results of transvenous occlusion of secundum atrial septal defects with the fourth generation buttoned device: Comparison with first, second and third generation devices. International Buttoned Device Trial Group. J Am Coll Cardiol 2000 36 : 583 592.
53. Rickers C, Hamm C, Stern H, et al. Percutaneous closure of secundum atrial septal defect with a new self centering device ("angel wings"). Heart 1998 80 : 517 521.
54. Rome JJ, Keane JF, Perry SB, et al. Double-umbrella closure of atrial defects. Initial clinical applications. Circulation 1990 82 : 751 758.
55. Fredriksen PM, Veldtman G, Hechter S, et al. Aerobic capacity in adults with various congenital heart diseases. Am J Cardiol 2001 87 : 310 314.
56. Steele PM, Fuster V, Cohen M, et al. Isolated atrial septal defect with pulmonary vascular obstructive disease-long-term follow-up and prediction of outcome after surgical correction. Circulation 1987 76 : 1037 1042.
57. Bolger AP, Sharma R, Li W, et al. Neurohormonal activation and the chronic heart failure syndrome in adults with congenital heart disease. Circulation 2002 106 : 92 99.
58. Brochu MC, Baril JF, Dore A, et al. Improvement in exercise capacity in asymptomatic and mildly symptomatic adults after atrial septal defect percutaneous closure. Circulation 2002 106 : 1821 1826.
59. Murphy JG, Gersh BJ, McGoon MD, et al. Long-term outcome after surgical repair of isolated atrial septal defect. Follow-up at 27 to 32 years. N Engl J Med 1990 323 : 1645 1650.
60. Patel A, Lopez K, Banerjee A, et al. Transcatheter closure of atrial septal defects in adults > or = 40 years of age: Immediate and follow-up results. J Interv Cardiol 2007 20 : 82 88.
61. Schoen SP, Kittner T, Bohl S, et al. Transcatheter closure of atrial septal defects improves right ventricular volume, mass, function, pulmonary pressure, and functional class: A magnetic resonance imaging study. Heart 2006 92 : 821 826.
62. Wu ET, Akagi T, Taniguchi M, et al. Differences in right and left ventricular remodeling after transcatheter closure of atrial septal defect among adults. Catheter Cardiovasc Interv 2007 69 : 866 871.
63. Holzer R, Cao QL, Hijazi ZM. Closure of a moderately large atrial septal defect with a self-fabricated fenestrated Amplatzer septal occluder in an 85-year-old patient with reduced diastolic elasticity of the left ventricle. Catheter Cardiovasc Interv 2005 64 : 513 518 discussion 9-21.
64. Webb G, Gatzoulis MA. Atrial septal defects in the adult: Recent progress and overview. Circulation 2006 114 : 1645 1653.
65. Kim JJ, Hijazi ZM. Clinical outcomes and costs of Amplatzer transcatheter closure as compared with surgical closure of ostium secundum atrial septal defects. Med Sci Monit 2002 8 : CR787 CR791.
66. Thomson JD, Aburawi EH, Watterson KG, et al. Surgical and transcatheter (Amplatzer) closure of atrial septal defects: A prospective comparison of results and cost. Heart 2002 87 : 466 469.
67. Vincent RN, Raviele AA, Diehl HJ. Single-center experience with the HELEX septal occluder for closure of atrial septal defects in children. J Interv Cardiol 2003 16 : 79 82.
68. Harper RW, Mottram PM, McGaw DJ. Closure of secundum atrial septal defects with the Amplatzer septal occluder device: Techniques and problems. Catheter Cardiovasc Interv 2002 57 : 508 524.
69. Divekar A, Gaamangwe T, Shaikh N, et al. Cardiac perforation after device closure of atrial septal defects with the Amplatzer septal occluder. J Am Coll Cardiol 2005 45 : 1213 1218.
70. Amin Z, Hijazi ZM, Bass JL, et al. Erosion of Amplatzer septal occluder device after closure of secundum atrial septal defects: Review of registry of complications and recommendations to minimize future risk. Catheter Cardiovasc Interv 2004 63 : 496 502.
71. Sharifi M, Dehghani M, Mehdipour M, et al. Intense migraines secondary to percutaneous closure of atrial septal defects. J Interv Cardiol 2005 18 : 181 183.
72. Sharifi M, Burks J. Efficacy of clopidogrel in the treatment of post-ASD closure migraines. Catheter Cardiovasc Interv 2004 63 : 255.
73. Wilmshurst PT, Nightingale S, Walsh KP, et al. Clopidogrel reduces migraine with aura after transcatheter closure of persistent foramen ovale and atrial septal defects. Heart 2005 91 : 1173 1175.
74. Butera G, Chessa M, Carminati M. Percutaneous closure of ventricular septal defects. State of the art. J Cardiovasc Med (Hagerstown) 2007 8 : 39 45.
75. Hijazi ZM. Device closure of ventricular septal defects. Catheter Cardiovasc Interv 2003 60 : 107 114.
76. Rudolph AM. Ventricular septal defect. In : Rudolph AM, ed. Congenital Diseases of the Heart: Clinical-Physiological Considerations. 2nd ed. Armonk, NY : Futura Publishing Company, 2004, pp. 197 244.
77. Warnes CA, Liberthson R, Danielson GK, et al. Task force 1: The changing profile of congenital heart disease in adult life. J Am Coll Cardiol 2001 37 : 1170 1175.
78. Soto B, Becker AE, Moulaert AJ, et al. Classification of ventricular septal defects. Br Heart J 1980 43 : 332 343.
79. Minette MS, Sahn DJ. Ventricular septal defects. Circulation 2006 114 : 2190 2197.
80. Mavroudis C, Baker CL, F.S. I. Ventricular septal defect. In : Mavroudis C, Baker CL, eds. Pediatric Cardiac Surgery. 2nd ed. St. Louis : Mosby, 1994, pp. 201 224.
81. Thanopoulos BD. Catheter closure of perimembranous/membranous ventricular septal defects using the Amplatzer occluder device. Pediatr Cardiol 2005 26 : 311 314.
82. Kirklin JK, Castaneda AR, Keane JF, et al. Surgical management of multiple ventricular septal defects. J Thorac Cardiovasc Surg 1980 80 : 485 493.
83. Anderson RH, Becker AE, Tynan M. Description of ventricular septal defects-or how long is a piece of string? Int J Cardiol 1986 13 : 267 278.
84. Edwards BS, Edwards WD, Edwards JE. Ventricular septal rupture complicating acute myocardial infarction: Identification of simple and complex types in 53 autopsied hearts. Am J Cardiol 1984 54 : 1201 1205.
85. Pate GE, Al Zubaidi A, Chandavimol M, et al. Percutaneous closure of prosthetic paravalvular leaks: Case series and review. Catheter Cardiovasc Interv 2006 68 : 528 533.
86. Pate GE, Thompson CR, Munt BI, et al. Techniques for percutaneous closure of prosthetic paravalvular leaks. Catheter Cardiovasc Interv 2006 67 : 158 166.
87. Webb JG, Pate GE, Munt BI. Percutaneous closure of an aortic prosthetic paravalvular leak with an Amplatzer duct occluder. Catheter Cardiovasc Interv 2005 65 : 69 72.
88. Crenshaw BS, Granger CB, Birnbaum Y, et al. Risk factors, angiographic patterns, and outcomes in patients with ventricular septal defect complicating acute myocardial infarction. GUSTO-I (Global Utilization of Streptokinase and TPA for Occluded Coronary Arteries) Trial Investigators. Circulation 2000 101 : 27 32.
89. Holzer R, Hijazi ZM. Interventional approach to congenital heart disease. Curr Opin Cardiol 2004 19 : 84 90.
90. Labrousse L, Choukroun E, Chevalier JM, et al. Surgery for postinfarction ventricular septal defect (VSD): Risk factors for hospital death and long term results. Eur J Cardiothorac Surg 2002 21 : 725 731 discussion 31-32.
91. Chessa M, Carminati M, Cao QL, et al. Transcatheter closure of congenital and acquired muscular ventricular septal defects using the Amplatzer device. J Invasive Cardiol 2002 14 : 322 327.
92. Goldstein JA, Casserly IP, Balzer DT, et al. Transcatheter closure of recurrent postmyocardial infarction ventricular septal defects utilizing the Amplatzer postinfarction VSD device: A case series. Catheter Cardiovasc Interv 2003 59 : 238 243.
93. Szkutnik M, Bialkowski J, Kusa J, et al. Postinfarction ventricular septal defect closure with Amplatzer occluders. Eur J Cardiothorac Surg 2003 23 : 323 327.
94. Holzer R, Balzer D, Amin Z, et al. Transcatheter closure of postinfarction ventricular septal defects using the new Amplatzer muscular VSD occluder: Results of a U.S. Registry. Catheter Cardiovasc Interv 2004 61 : 196 201.
95. Bass JL, Kalra GS, Arora R, et al. Initial human experience with the Amplatzer perimembranous ventricular septal occluder device. Catheter Cardiovasc Interv 2003 58 : 238 245.
96. Carminati M, Butera G, Chessa M, et al. Transcatheter closure of congenital ventricular septal defect with Amplatzer septal occluders. Am J Cardiol 2005 96 : 52L 58L.
97. Gu X, Han YM, Titus JL, et al. Transcatheter closure of membranous ventricular septal defects with a new nitinol prosthesis in a natural swine model. Catheter Cardiovasc Interv 2000 50 : 502 509.
98. Hijazi ZM, Hakim F, Haweleh AA, et al. Catheter closure of perimembranous ventricular septal defects using the new Amplatzer membranous VSD occluder: Initial clinical experience. Catheter Cardiovasc Interv 2002 56 : 508 515.
99. Holzer R, Balzer D, Cao QL, et al. Device closure of muscular ventricular septal defects using the Amplatzer muscular ventricular septal defect occluder: Immediate and mid-term results of a U.S. registry. J Am Coll Cardiol 2004 43 : 1257 1263.
100. Arora R, Trehan V, Kumar A, et al. Transcatheter closure of congenital ventricular septal defects: Experience with various devices. J Interv Cardiol 2003 16 : 83 91.
101. Arora R, Trehan V, Thakur AK, et al. Transcatheter closure of congenital muscular ventricular septal defect. J Interv Cardiol 2004 17 : 109 115.
102. Masura J, Gao W, Gavora P, et al. Percutaneous closure of perimembranous ventricular septal defects with the eccentric Amplatzer device: Multicenter follow-up study. Pediatr Cardiol 2005 26 : 216 219.
103. Fu YC, Bass J, Amin Z, et al. Transcatheter closure of perimembranous ventricular septal defects using the new Amplatzer membranous VSD occluder: Results of the U.S. phase I trial. J Am Coll Cardiol 2006 47 : 319 325.
104. Bridges ND, Perry SB, Keane JF, et al. Preoperative transcatheter closure of congenital muscular ventricular septal defects. N Engl J Med 1991 324 : 1312 1317.
105. Kalra GS, Verma PK, Dhall A, et al. Transcatheter device closure of ventricular septal defects: Immediate results and intermediate-term follow-up. Am Heart J 1999 138 : 339 344.
106. Rigby ML, Redington AN. Primary transcatheter umbrella closure of perimembranous ventricular septal defect. Br Heart J 1994 72 : 368 371.
107. Holzer R, de Giovanni J, Walsh KP, et al. Transcatheter closure of perimembranous ventricular septal defects using the amplatzer membranous VSD occluder: Immediate and midterm results of an international registry. Catheter Cardiovasc Interv 2006 68 : 620 628.
108. Napoleone CP, Gargiulo G. Septal defects: Surgeons do it better. J Cardiovasc Med (Hagerstown) 2007 8 : 46 49.
109. Hannan RL, McDaniel N, Kron IL. As originally published in 1989: Repair of large muscular ventricular septal defects in infants employing left ventriculotomy. Updated in 1996. Ann Thorac Surg 1997 63 : 288 289.
110. Stellin G, Padalino M, Milanesi O, et al. Surgical closure of apical ventricular septal defects through a right ventricular apical infundibulotomy. Ann Thorac Surg 2000 69 : 597 601.
111. Hijazi ZM, Hakim F, Al-Fadley F, et al. Transcatheter closure of single muscular ventricular septal defects using the amplatzer muscular VSD occluder: Initial results and technical considerations. Catheter Cardiovasc Interv 2000 49 : 167 172.
112. Thanopoulos BD, Rigby ML. Outcome of transcatheter closure of muscular ventricular septal defects with the Amplatzer ventricular septal defect occluder. Heart 2005 91 : 513 516.
113. Bouchart F, Bessou JP, Tabley A, et al. Urgent surgical repair of postinfarction ventricular septal rupture: Early and late outcome. J Card Surg 1998 13 : 104 112.
114. Martinez MW, Mookadam F, Sun Y, et al. Transcatheter closure of ischemic and post-traumatic ventricular septal ruptures. Catheter Cardiovasc Interv 2007 69 : 403 407.
115. Fraisse A, Piechaud JF, Avierinos JF, et al. Transcatheter closure of traumatic ventricular septal defect: An alternative to surgical repair? Ann Thorac Surg 2002 74 : 582 584.
116. Pesenti-Rossi D, Godart F, Dubar A, et al. Transcatheter closure of traumatic ventricular septal defect: An alternative to surgery. Chest 2003 123 : 2144 2145.
117. Francis E, Sivakumar K, Kumar RK. Transcatheter closure of fistula between the right pulmonary artery and left atrium using the Amplatzer duct occluder. Catheter Cardiovasc Interv 2004 63 : 83 86.
118. Alzubaidi A, MacDonald S, Clement J, et al. Percutaneous closure of a para-anastomotic abdominal aortic graft leak. Catheter Cardiovasc Interv 2006 68 : 799 802.
119. Bashir F, Quaife R, Carroll JD. Percutaneous closure of ascending aortic pseudoaneurysm using Amplatzer septal occluder device: The first clinical case report and literature review. Catheter Cardiovasc Interv 2005 65 : 547 551.
120. Clift P, Thorne S, de Giovanni J. Percutaneous device closure of a pseudoaneurysm of the left ventricular wall. Heart 2004 90 : e62.
121. Shapira Y, Hirsch R, Kornowski R, et al. Percutaneous closure of perivalvular leaks with Amplatzer occluders: Feasibility, safety, and short-term results. J Heart Valve Dis 2007 16 : 305 313.
122. Chen MY, Quaife RA, Groves BM, et al. Cardiac computed tomographic angiography pre-procedural planning for percutaneous atrial septal defect closure. Presented at the 2006 AHA Scientific Sessions.
123. Gade CL, Bergman G, Naidu S, et al. Comprehensive evaluation of atrial septal defects in individuals undergoing percutaneous repair by 64-detector row computed tomography. Int J Cardiovasc Imaging 2007 23 : 397 404.
124. Bill JS, Reuther JF, Dittmann W, et al. Stereolithography in oral and maxillofacial operation planning. Int J Oral Maxillofac Surg 1995 24 : 98 103.
125. D'Urso PS, Thompson RG, Atkinson RL, et al. Cerebrovascular biomodelling: A technical note. Surg Neurol 1999 52 : 490 500.
126. Webb PA. A review of rapid prototyping (RP) techniques in the medical and biomedical sector. J Med Eng Technol 2000 24 : 149 153.
127. Ngan EM, Rebeyka IM, Ross DB, et al. The rapid prototyping of anatomic models in pulmonary atresia. J Thorac Cardiovasc Surg 2006 132 : 264 269.
128. Noecker AM, Chen JF, Zhou Q, et al. Development of patient-specific three-dimensional pediatric cardiac models. ASAIO J 2006 52 : 349 353.
129. Sodian R, Loebe M, Hein A, et al. Application of stereolithography for scaffold fabrication for tissue engineered heart valves. ASAIO J 2002 48 : 12 16.
130. Marx GR, Su X. Three-dimensional echocardiography in congenital heart disease. Cardiol Clin 2007 25 : 357 365.
131. Gill EA, Liang DH. Interventional three-dimensional echocardiography: Using real-time three-dimensional echocardiography to guide and evaluate intracardiac therapies. Cardiol Clin 2007 25 : 335 340.
132. Seymour NE, Gallagher AG, Roman SA, et al. Virtual reality training improves operating room performance: Results of a randomized, double-blinded study. Ann Surg 2002 236 : 458 463 discussion 63-64.
133. Aggarwal R, Tully A, Grantcharov T, et al. Virtual reality simulation training can improve technical skills during laparoscopic salpingectomy for ectopic pregnancy. BJOG 2006 113 : 1382 1387.
134. Chaer RA, Derubertis BG, Lin SC, et al. Simulation improves resident performance in catheter-based intervention: Results of a randomized, controlled study. Ann Surg 2006 244 : 343 352.
135. Dayal R, Faries PL, Lin SC, et al. Computer simulation as a component of catheter-based training. J Vasc Surg 2004 40 : 1112 1117.